CRWV insider plans sale of 32,456 shares

CRWV has a Form 144 notice indicating an intended sale of 32,456 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $3,533,160.16, on or after 01/28/2026 on NASDAQ.

Accepted by SEC EDGAR 01/28/2026 - 04:21 PM EST Learn about SEC filing dates

Rhea-AI Filing Summary

CRWV has a Form 144 notice indicating an intended sale of 32,456 common shares through Morgan Stanley Smith Barney LLC, with an aggregate market value of $3,533,160.16, on or after 01/28/2026 on NASDAQ.

The shares were acquired as founder shares from the issuer on 11/13/2017. The filing also lists recent Rule 10b5-1 and other sales of CRWV common stock over the past three months, including individual transactions such as 32,455 shares sold for $2,904,243.32 and 50,000-share sales by OMNADORA CAPITAL LLC.

The table notes 386,401,201 common shares outstanding for context.

Insights

Equity markets analyst

Form 144 discloses a planned CRWV insider share sale and recent 10b5-1 activity.

This Form 144 shows a holder of CRWV common stock planning to sell 32,456 shares via Morgan Stanley Smith Barney LLC, with an indicated market value of $3,533,160.16. The shares were originally acquired as founder shares on 11/13/2017 directly from the issuer.

The filing also details multiple recent sales under Rule 10b5-1 and other transactions in the past three months, including several 32,455–32,456 share trades and 50,000-share trades by OMNADORA CAPITAL LLC, each with multi-million dollar gross proceeds. These disclosures outline historical and prospective liquidity events for existing holders rather than new issuance by the company.

Because this activity involves secondary sales of existing shares, not capital raised by the company, the direct effect is on ownership composition and trading supply. Actual impact depends on the scale of these sales relative to overall trading volume and the 386,401,201 shares reported as outstanding.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the CRWV Form 144 filing disclose about planned share sales?

The Form 144 indicates a CRWV shareholder plans to sell 32,456 common shares through Morgan Stanley Smith Barney LLC. The filing shows an aggregate market value of $3,533,160.16 and lists NASDAQ as the securities exchange for the planned transaction.

How many CRWV shares are reported as outstanding in this Form 144?

The Form 144 reports 386,401,201 CRWV common shares outstanding. This figure provides context for the planned 32,456-share sale and helps investors gauge the relative size of the disclosed transactions against the company’s total share count.

When were the CRWV shares in the Form 144 originally acquired and how?

The 32,456 CRWV shares covered by the Form 144 were acquired on 11/13/2017 as founder shares from the issuer. The table records the nature of the acquisition as “Founders Shares” and notes the same date for acquisition and payment.

What recent CRWV stock sales are listed alongside the Form 144 notice?

The filing lists multiple CRWV common stock sales during the past three months, including several Rule 10b5-1 trades for Michael Intrator and OMNADORA CAPITAL LLC. Individual transactions include 32,455-share sales and 50,000-share sales with multi-million-dollar gross proceeds.

Which broker is named in the CRWV Form 144 filing and what market is used?

The Form 144 names Morgan Stanley Smith Barney LLC Executive Financial Services as the broker for the planned sale. It identifies NASDAQ as the securities exchange where the 32,456 CRWV common shares are expected to be sold.

What representation does the selling person make in the CRWV Form 144?

The seller represents that they do not know any material adverse, non-public information about CRWV’s current or prospective operations. This representation is required when using Form 144 and, if applicable, when relying on a written Rule 10b5-1 trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002058037
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	COREWEAVE, INC.
SEC File Number	001-42563
Address of Issuer	290 W Mt. Pleasant Ave. Suite 4100 Livingston NEW JERSEY 07039
Phone	9732709737
Name of Person for Whose Account the Securities are To Be Sold	MICHAEL INTRATOR
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer
Relationship to Issuer	10% Stockholder

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	32456	3533160.16	386401201	01/28/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	11/13/2017	Founders Shares	Issuer			32456	11/13/2017	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	32455	2901243.32
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/14/2026	50000	4469640.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	01/06/2026	61386	4674746.47
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	32456	2334725.61
MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	78971	5731033.94
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/31/2025	50000	3596755.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	32455	2124981.39
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/17/2025	50000	3273735.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	32455	2495279.96
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	12/03/2025	50000	3844215.00
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	32455	2424654.63
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/19/2025	50000	3735410.00
Non-Affiliate Donee 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/14/2025	75000	5946097.50
10b5-1 Sales for MICHAEL INTRATOR 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	32455	3698951.52
10b5-1 Sales for OMNADORA CAPITAL LLC 290 W Mt. Pleasant Ave. Suite 4100 Livingston NJ 07039	Common	11/05/2025	50000	5698585.00

144: Remarks and Signature

Remarks
Date of Notice	01/28/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	05/23/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Michael Intrator
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)